# Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers

> **NCT04928703** · EARLY_PHASE1 · COMPLETED · sponsor: **ERP Biomarker Qualification Consortium** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04928703
- **Lead sponsor:** ERP Biomarker Qualification Consortium
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-26
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04928703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04928703, "Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT04928703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*